Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
MIST Milestone Pharmaceuticals
- 1.310
- -0.010-0.76%
Close May 2 16:00 ET
- 1.320
- +0.010+0.76%
Post 19:49 ET
69.89MMarket Cap-1.96P/E (TTM)
1.460High1.280Low1.90MVolume1.340Open1.320Pre Close2.56MTurnover3.59%Turnover RatioLossP/E (Static)53.35MShares2.75052wk High5.33P/B69.44MFloat Cap0.62552wk Low--Dividend TTM53.00MShs Float27.950Historical High--Div YieldTTM13.64%Amplitude0.625Historical Low1.347Avg Price1Lot Size
About Milestone Pharmaceuticals Company
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.
Company Profile
SymbolMIST
Company NameMilestone Pharmaceuticals
Listing DateMay 9, 2019
Issue Price15.00
Founded2003
CEOMr. Joseph G. Oliveto
MarketNASDAQ
Employees33
Fiscal Year Ends12-31
Address1111 Dr. Frederik-Philips Boulevard,Suite 420
CityMontréal
ProvinceQuébec
CountryCanada
Zip CodeH4M 2X6
Phone1-514-336-0444
Company Executives
- Name
- Position
- Salary
- Joseph G. Oliveto
- Director, President and Chief Executive Officer
- 1.98M
- Lorenz Muller
- Chief Commercial Officer
- --
- Jeffrey Edward Nelson
- Chief Operating Officer
- --
- Dr. David Bharucha, M.D.,PhD
- Chief Medical Officer
- 1.22M
- Amit Hasija
- Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Corporate Development
- 1.01M
- Dr. Robert J. Wills, PhD
- Chairman of the Board
- 176.77K
- Joseph C. Papa
- Director
- --
- Lisa M. Giles
- Independent Director
- 155.77K
- Stuart M. Duty
- Independent Director
- --
- Seth H.Z. Fischer
- Independent Director
- 253.86K
- Michael J. Tocek, M.B.A.
- Independent Director
- 153.27K
- Andrew Saik
- Independent Director
- --
Market Insights
Discussing
BRK cash at new high: What to expect from Buffett’s meeting?
🎙️Discussion 1. Buffett said he won't sell Japanese stocks for the next ten years. What's your take? 2. In the face of market changes, do y
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
